C161H252N18O11S5 — CID 160563351
3-tert-butyl-N-[2-(1H-imidazol-2-yl)ethyl]benzamide;2-tert-butyl-N-methyl-N-[(1-methylazetidin-3-yl)methyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[2-[methyl(propan-2-yl)amino]ethyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[[(3R)-1-methylpyrrolidin-3-yl]methyl]benzenesulfonamide;2-tert-butyl-1-methyl-4-phenylimidazole;2-(2-tert-butylphenyl)-1-methylpiperidine;(3S)-3-(2-tert-butylphenyl)piperidine;(3R)-3-(2-tert-butylphenyl)piperidine;N-(3-tert-butyl-2-piperidin-3-ylphenyl)methanesulfonamide;N-[3-tert-butyl-2-(1-propan-2-ylpiperidin-3-yl)phenyl]methanesulfonamide (PubChem CID 160563351) has the molecular formula C161H252N18O11S5 and a molecular weight of 2776.24 g/mol. Its IUPAC name is 3-tert-butyl-N-[2-(1H-imidazol-2-yl)ethyl]benzamide;2-tert-butyl-N-methyl-N-[(1-methylazetidin-3-yl)methyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[2-[methyl(propan-2-yl)amino]ethyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[[(3R)-1-methylpyrrolidin-3-yl]methyl]benzenesulfonamide;2-tert-butyl-1-methyl-4-phenylimidazole;2-(2-tert-butylphenyl)-1-methylpiperidine;(3S)-3-(2-tert-butylphenyl)piperidine;(3R)-3-(2-tert-butylphenyl)piperidine;N-(3-tert-butyl-2-piperidin-3-ylphenyl)methanesulfonamide;N-[3-tert-butyl-2-(1-propan-2-ylpiperidin-3-yl)phenyl]methanesulfonamide.
| Compound Name | 3-tert-butyl-N-[2-(1H-imidazol-2-yl)ethyl]benzamide;2-tert-butyl-N-methyl-N-[(1-methylazetidin-3-yl)methyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[2-[methyl(propan-2-yl)amino]ethyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[[(3R)-1-methylpyrrolidin-3-yl]methyl]benzenesulfonamide;2-tert-butyl-1-methyl-4-phenylimidazole;2-(2-tert-butylphenyl)-1-methylpiperidine;(3S)-3-(2-tert-butylphenyl)piperidine;(3R)-3-(2-tert-butylphenyl)piperidine;N-(3-tert-butyl-2-piperidin-3-ylphenyl)methanesulfonamide;N-[3-tert-butyl-2-(1-propan-2-ylpiperidin-3-yl)phenyl]methanesulfonamide |
|---|---|
| PubChem CID | 160563351 |
| Molecular Formula | C161H252N18O11S5 |
| Molecular Weight | 2776.24 g/mol |
| Exact Mass | 2773.83 |
| IUPAC Name | 3-tert-butyl-N-[2-(1H-imidazol-2-yl)ethyl]benzamide;2-tert-butyl-N-methyl-N-[(1-methylazetidin-3-yl)methyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[2-[methyl(propan-2-yl)amino]ethyl]benzenesulfonamide;2-tert-butyl-N-methyl-N-[[(3R)-1-methylpyrrolidin-3-yl]methyl]benzenesulfonamide;2-tert-butyl-1-methyl-4-phenylimidazole;2-(2-tert-butylphenyl)-1-methylpiperidine;(3S)-3-(2-tert-butylphenyl)piperidine;(3R)-3-(2-tert-butylphenyl)piperidine;N-(3-tert-butyl-2-piperidin-3-ylphenyl)methanesulfonamide;N-[3-tert-butyl-2-(1-propan-2-ylpiperidin-3-yl)phenyl]methanesulfonamide |
| SMILES | CC(C)(C)c1cccc(C(=O)NCCc2ncc[nH]2)c1.CC(C)(C)c1cccc(NS(C)(=O)=O)c1C1CCCNC1.CC(C)(C)c1ccccc1[C@@H]1CCCNC1.CC(C)(C)c1ccccc1[C@H]1CCCNC1.CC(C)N(C)CCN(C)S(=O)(=O)c1ccccc1C(C)(C)C.CC(C)N1CCCC(c2c(NS(C)(=O)=O)cccc2C(C)(C)C)C1.CN1CC(CN(C)S(=O)(=O)c2ccccc2C(C)(C)C)C1.CN1CCCCC1c1ccccc1C(C)(C)C.CN1CC[C@@H](CN(C)S(=O)(=O)c2ccccc2C(C)(C)C)C1.Cn1cc(-c2ccccc2)nc1C(C)(C)C |
| InChI | InChI=1S/C19H32N2O2S.C17H28N2O2S.C17H30N2O2S.C16H21N3O.2C16H26N2O2S.C16H25N.2C15H23N.C14H18N2/c1-14(2)21-12-8-9-15(13-21)18-16(19(3,4)5)10-7-11-17(18)20-24(6,22)23;1-17(2,3)15-8-6-7-9-16(15)22(20,21)19(5)13-14-10-11-18(4)12-14;1-14(2)18(6)12-13-19(7)22(20,21)16-11-9-8-10-15(16)17(3,4)5;1-16(2,3)13-6-4-5-12(11-13)15(20)19-8-7-14-17-9-10-18-14;1-16(2,3)14-8-6-7-9-15(14)21(19,20)18(5)12-13-10-17(4)11-13;1-16(2,3)13-8-5-9-14(18-21(4,19)20)15(13)12-7-6-10-17-11-12;1-16(2,3)14-10-6-5-9-13(14)15-11-7-8-12-17(15)4;2*1-15(2,3)14-9-5-4-8-13(14)12-7-6-10-16-11-12;1-14(2,3)13-15-12(10-16(13)4)11-8-6-5-7-9-11/h7,10-11,14-15,20H,8-9,12-13H2,1-6H3;6-9,14H,10-13H2,1-5H3;8-11,14H,12-13H2,1-7H3;4-6,9-11H,7-8H2,1-3H3,(H,17,18)(H,19,20);6-9,13H,10-12H2,1-5H3;5,8-9,12,17-18H,6-7,10-11H2,1-4H3;5-6,9-10,15H,7-8,11-12H2,1-4H3;2*4-5,8-9,12,16H,6-7,10-11H2,1-3H3;5-10H,1-4H3/t;14-;;;;;;2*12-;/m.1.....10./s1 |
| InChIKey | QZPKCPHSMQEVMI-HTZTUXRKSA-N |
| XLogP | 31.54 |
| TPSA | 332.37 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 195 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2776.24 |
| LogP ≤ 5 | 31.54 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 22 |